株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

糖鎖生物学の世界市場 〜2021年:酵素:グリコシルトランスフェラーゼ、ノイラミニダーゼ、グリコシダーゼ、設備:HPLC、質量分析計、MALDI-TOF、キット・試薬

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application, End User - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 315373
出版日 ページ情報 英文 160 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.05円で換算しております。
Back to Top
糖鎖生物学の世界市場 〜2021年:酵素:グリコシルトランスフェラーゼ、ノイラミニダーゼ、グリコシダーゼ、設備:HPLC、質量分析計、MALDI-TOF、キット・試薬 Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application, End User - Global Forecast to 2021
出版日: 2017年01月30日 ページ情報: 英文 160 Pages
概要

世界の糖鎖生物学市場は2016年に6億4,950万米ドルに達し、2016〜2021年はCAGR13.3%で推移し、2021年には12億1,140万米ドルに達すると予測されています。政府および民間企業がプロテオミクスや糖鎖私物学の研究資金を増加したことと、製薬会社やバイオテクノロジー企業が研究開発費を急速に拡大したことが同市場の成長を大きく支える二大要因となっています。その一方で、企業の合併が相次いでいることが市場への新規参入を抑制し、それによって成長が妨げられるとも見られています。

当レポートは、世界の糖鎖生物学市場について調査し、用途別、エンドユーザー別、製品別、および地域別の動向、市場に参入する主要企業のシェアとプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

  • 糖鎖生物学市場の概要
  • 地理的分析:製品別糖鎖生物学市場
  • 地域別ライフサイクル分析

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 製品別市場

  • イントロダクション
  • 酵素
    • グリコシダーゼ
    • グリコシルトランスフェラーゼ
    • ノイラミニダーゼ
    • シアリルトランスフェラーゼ
    • その他
  • 設備
    • 抗体アレイ
    • HPLC
    • レクチンアレイ
    • MALDI-TOF
    • 質量分析計
    • その他
  • キット
    • グリカンラベリングキット
    • グリカン精製キット
    • グリカンリリースキット
    • その他
  • 試薬
    • 糖タンパク質
    • 単糖
    • オリゴ糖
    • その他

第7章 用途別市場

  • イントロダクション
  • 診断
  • 創薬・薬剤開発
  • 腫瘍学
  • 免疫学
  • その他

第8章 エンドユーザー別市場

  • イントロダクション
  • 学術研究機関
  • 製薬会社・バイオテクノロジー企業
  • CRO(開発業務受託機関)

第9章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第10章 競合環境

  • 市場シェア分析
    • 糖鎖生物学酵素、キット、試薬市場
    • 糖鎖生物学設備市場
  • 競合動向
    • 新製品上市
    • 拡大
    • 合意
    • 買収、協業、認可、その他

第11章 企業プロファイル

  • イントロダクション
  • Merck KGaA
  • タカラバイオ
  • 島津製作所
  • Bruker Corporation
  • Waters Corporation
  • New England Biolabs Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • ProZyme, Inc.
  • Thermo Fisher Scientific, Inc.

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2776

The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region.

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the global glycomics/glycobiology market.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the glycomics/glycobiology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a higher market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the glycomics/glycobiology market. The report analyzes the glycomics/glycobiology by product, application, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the glycomics/glycobiology market
  • Competitive Assessment: In-depth assessment of the market strategies, regional and business segments, and product portfolios of the leading players in the glycomics/glycobiology market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various glycomics/glycobiology offerings across regions
  • Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the glycomics/glycobiology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKETS DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. MARKET SCOPE
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLYCOMICS: MARKET OVERVIEW (2016-2021)
  • 4.2. GEOGRAPHIC ANALYSIS: GLYCOMICS MARKET, BY PRODUCT
  • 4.3. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
      • 5.2.1.1. Growth of the Proteomics Market
      • 5.2.1.2. Technological Advancements in Glycomics Instrumentation
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High Degree of Consolidation Hinders Entry of New Players to the Market
      • 5.2.2.2. Stringent Regulatory Frameworks and Time-consuming Approval Processes
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increased Use of Personalized Medicine
      • 5.2.3.2. Biomarker Identification
      • 5.2.3.3. Developing Countries and Emerging Markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. High Costs of Tools & Instruments and Their Maintenance

6. GLYCOMICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ENZYMES
    • 6.2.1. GLYCOSIDASES
    • 6.2.2. GLYCOSYLTRANSFERASES
    • 6.2.3. NEURAMINIDASES
    • 6.2.4. SIALYLTRANSFERASES
    • 6.2.5. OTHER GLYCOMICS ENZYMES
  • 6.3. INSTRUMENTS
    • 6.3.1. ANTIBODY ARRAYS
    • 6.3.2. HPLC
    • 6.3.3. LECTIN ARRAYS
    • 6.3.4. MALDI-TOF
    • 6.3.5. MASS SPECTROMETERS
    • 6.3.6. OTHER GLYCOMICS INSTRUMENTS
  • 6.4. KITS
    • 6.4.1. GLYCAN LABELING KITS
    • 6.4.2. GLYCAN PURIFICATION KITS
    • 6.4.3. GLYCAN RELEASE KITS
    • 6.4.4. OTHER GLYCOMICS KITS
  • 6.5. REAGENTS
    • 6.5.1. GLYCOPROTEINS
    • 6.5.2. MONOSACCHARIDES
    • 6.5.3. OLIGOSACCHARIDES
    • 6.5.4. OTHER REAGENTS

7. GLYCOMICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DIAGNOSTICS
  • 7.3. DRUG DISCOVERY & DEVELOPMENT
  • 7.4. ONCOLOGY
  • 7.5. IMMUNOLOGY
  • 7.6. OTHER APPLICATIONS

8. GLYCOMICS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC RESEARCH INSTITUTES
  • 8.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS

9. GLYCOMICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. ROE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. SOUTH AMERICA
    • 9.5.2. MIDDLE EAST AND AFRICA
    • 9.5.3. PACIFIC AND OCEANIA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. GLYCOMICS ENZYMES, KITS, AND REGENTS
    • 10.2.2. GLYCOMICS INSTRUMENTS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES
    • 10.3.2. EXPANSIONS
    • 10.3.3. AGREEMENTS
    • 10.3.4. ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. MERCK KGAA
  • 11.3. TAKARA BIO, INC.
  • 11.4. SHIMADZU CORPORATION
  • 11.5. BRUKER CORPORATION
  • 11.6. WATERS CORPORATION
  • 11.7. NEW ENGLAND BIOLABS INC.
  • 11.8. AGILENT TECHNOLOGIES, INC.
  • 11.9. DANAHER CORPORATION
  • 11.10. PROZYME, INC.
  • 11.11. THERMO FISHER SCIENTIFIC, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLYCOMICS MARKET SUMMARY
  • TABLE 2: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 3: GLYCOMICS ENZYMES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 4: GLYCOMICS ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: GLYCOSIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLYCOSYLTRANSFERASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NEURAMINIDASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: SIALYLTRANSFERASES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: OTHER GLYCOMICS ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ANTIBODY ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: HPLC MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: LECTIN ARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: MALDI-TOF MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: MASS SPECTROMETRY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: OTHER GLYCOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLYCAN LABELING KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: GLYCAN PURIFICATION KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLYCAN RELEASE KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: OTHER GLYCOMICS KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 25: GLYCOMICS REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: GLYCOPROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MONOSACCHARIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: OTHER REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 31: GLYCOMICS MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: GLYCOMICS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: GLYCOMICS MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: GLYCOMICS MARKET SIZE FOR IMMUNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: GLYCOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 37: GLYCOMICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: GLYCOMICS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLYCOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: GLYCOMICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: CANADA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: EUROPE: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: U.K.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: ITALY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 63: SPAIN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: ROE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA: GLYCOMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ASIA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 73: CHINA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: JAPAN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: INDIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: ROA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: GLYCOMICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: GLYCOMICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: ROW: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 80: ROW: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: ROW: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: ROW: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: ROW: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: ROW: GLYCOMICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: SOUTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 86: MIDDLE EAST AND AFRICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 87: PACIFIC AND OCEANIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 88: PRODUCT LAUNCHES, 2013-2016
  • TABLE 89: EXPANSIONS, 2013-2016
  • TABLE 90: AGREEMENTS, 2013-2016
  • TABLE 91: ACQUISITIONS, COLLABORATIONS, APPROVALS, AND OTHERS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL GLYCOMICS MARKET
  • FIGURE 2: RESEARCH METHODOLOGY
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ENZYMES TO REGISTER THE HIGHEST CAGR BETWEEN 2016 & 2021
  • FIGURE 8: GLYCOSIDASES TO DOMINATE THE GLYCOMICS ENZYMES MARKET IN 2016
  • FIGURE 9: MASS SPECTROMETRY TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 10: GLYCAN RELEASE KITS TO DOMINATE THE GLYCOMICS KITS MARKET IN 2016
  • FIGURE 11: OLIGOSACCHARIDES TO COMMAND THE LARGEST SHARE OF THE GLYCOMICS REAGENTS MARKET IN 2016
  • FIGURE 12: INCREASING FUNDING IN GLYCOMICS AND PROTEOMICS RESEARCH TO DRIVE THE NORTH AMERICAN GLYCOMICS MARKET
  • FIGURE 13: INCREASING FUNDING FOR PROTEOMICS & GLYCOMICS RESEARCH IS AN IMPORTANT GROWTH DRIVER FOR THE GLYCOMICS MARKET
  • FIGURE 14: ENZYMES TO ACCOUNT FOR THE LARGEST PRODUCT SEGMENT OF THE GLYCOMICS MARKET IN 2016
  • FIGURE 15: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES FOR GLYCOMICS PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 17: INCREASING GOVERNMENT AND PRIVATE FUNDING FOR PROTEOMICS AND GLYCOMICS RESEARCH TO DRIVE THE DEMAND FOR GLYCOMICS PRODUCTS
  • FIGURE 18: GLYCOMICS MARKET IN ASIA TO REGISTER HIGHEST GROWTH DURING THE FORECAST
  • FIGURE 19: NORTH AMERICA: GLYCOMICS MARKET SNAPSHOT
  • FIGURE 20: ASIA: GLYCOMICS MARKET SNAPSHOT
  • FIGURE 21: KEY DEVELOPMENTS IN THE GLOBAL GLYCOMICS MARKET, 2013-2016
  • FIGURE 22: GLOBAL GLYCOMICS ENZYMES, KITS, AND REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 23: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE GLYCOMICS MARKET BETWEEN 2013 & 2016
  • FIGURE 24: GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS
  • FIGURE 25: MERCK KGAA: COMPANY SNAPSHOT (2015)
  • FIGURE 26: TAKARA BIO, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 27: SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 28: BRUKER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 29: WATERS CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 30: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 31: DANAHER CORPORATION COMPANY SNAPSHOT (2015)
  • FIGURE 32: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2015)
Back to Top